Telomere qPCR analyses using genomic DNA extracted from RAS and rad21;RAS tumor samples and from control brains revealed an increase of telomere content heterogeneity in the RAS samples, but similar-to-control telomere content in rad21;RAS tumors (Figure 2A). This evidence concerns the gene RAD21 and neoplasm.